{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:13:52Z","timestamp":1789902832945,"version":"4.0.1"},"reference-count":40,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1248\/bpb.b18-00369","type":"journal-article","created":{"date-parts":[[2019,3,31]],"date-time":"2019-03-31T18:03:13Z","timestamp":1554055393000},"page":"518-523","source":"Crossref","is-referenced-by-count":72,"title":["Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction"],"prefix":"10.1248","volume":"42","author":[{"given":"Masafumi","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Inflammation Research, Center for Molecular Medicine Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Anderson JL, Morrow DA. Acute Myocardial Infarction. N. Engl. J. Med.<\/i>, 376<\/b>, 2053\u20132064 (2017).","DOI":"10.1056\/NEJMra1606915"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N. Engl. J. Med.<\/i>, 357<\/b>, 1121\u20131135 (2007).","DOI":"10.1056\/NEJMra071667"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Takahashi M. NLRP3 inflammasome as a novel player in myocardial infarction. Int. Heart J.<\/i>, 55<\/b>, 101\u2013105 (2014).","DOI":"10.1536\/ihj.13-388"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Takahashi M. Role of the inflammasome in myocardial infarction. Trends Cardiovasc. Med.<\/i>, 21<\/b>, 37\u201341 (2011).","DOI":"10.1016\/j.tcm.2012.02.002"},{"key":"5","unstructured":"5) Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol.<\/i>, 10<\/b>, 826\u2013837 (2010)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yajima N, Takahashi M, Morimoto H, Shiba Y, Takahashi Y, Masumoto J, Ise H, Sagara J, Nakayama J, Taniguchi S, Ikeda U. Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation<\/i>, 117<\/b>, 3079\u20133087 (2008).","DOI":"10.1161\/CIRCULATIONAHA.107.746453"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, Hida S, Sagara J, Taniguchi S, Takahashi M. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem. Biophys. Res. Commun.<\/i>, 425<\/b>, 162\u2013168 (2012).","DOI":"10.1016\/j.bbrc.2012.07.058"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury. Circulation<\/i>, 123<\/b>, 594\u2013604 (2011).","DOI":"10.1161\/CIRCULATIONAHA.110.982777"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, Yoshimura K, Aoki H, Tsutsui H, Noda T, Sagara J, Taniguchi S, Takahashi M. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm. Arterioscler. Thromb. Vasc. Biol.<\/i>, 35<\/b>, 127\u2013136 (2015).","DOI":"10.1161\/ATVBAHA.114.303763"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol.<\/i>, 13<\/b>, 397\u2013411 (2013).","DOI":"10.1038\/nri3452"},{"key":"11","unstructured":"11) Robbins GR, Wen H, Ting JP. Inflammasomes and metabolic disorders: old genes in modern diseases. Mol. Cell<\/i>, 54<\/b>, 297\u2013308 (2014)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature<\/i>, 526<\/b>, 660\u2013665 (2015).","DOI":"10.1038\/nature15514"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, Liu PS, Lill JR, Li H, Wu J, Kummerfeld S, Zhang J, Lee WP, Snipas SJ, Salvesen GS, Morris LX, Fitzgerald L, Zhang Y, Bertram EM, Goodnow CC, Dixit VM. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature<\/i>, 526<\/b>, 666\u2013671 (2015).","DOI":"10.1038\/nature15541"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, Yang ZH, Zhong CQ, Han J. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res.<\/i>, 25<\/b>, 1285\u20131298 (2015).","DOI":"10.1038\/cr.2015.139"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) He Y, Hara H, Nunez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem. Sci.<\/i>, 41<\/b>, 1012\u20131021 (2016).","DOI":"10.1016\/j.tibs.2016.09.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Karasawa T, Takahashi M. Role of NLRP3 Inflammasomes in Atherosclerosis. J. Atheroscler. Thromb.<\/i>, 24<\/b>, 443\u2013451 (2017).","DOI":"10.5551\/jat.RV17001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mu\u00f1oz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity<\/i>, 38<\/b>, 1142\u20131153 (2013).","DOI":"10.1016\/j.immuni.2013.05.016"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) He Y, Zeng MY, Yang D, Motro B, Nunez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature<\/i>, 530<\/b>, 354\u2013357 (2016).","DOI":"10.1038\/nature16959"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shi H, Wang Y, Li X, Zhan X, Tang M, Fina M, Su L, Pratt D, Bu CH, Hildebrand S, Lyon S, Scott L, Quan J, Sun Q, Russell J, Arnett S, Jurek P, Chen D, Kravchenko VV, Mathison JC, Moresco EM, Monson NL, Ulevitch RJ, Beutler B. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol.<\/i>, 17<\/b>, 250\u2013258 (2016).","DOI":"10.1038\/ni.3333"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Schmid-Burgk JL, Chauhan D, Schmidt T, Ebert TS, Reinhardt J, Endl E, Hornung V. A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J. Biol. Chem.<\/i>, 291<\/b>, 103\u2013109 (2016).","DOI":"10.1074\/jbc.C115.700492"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Fry AM, O\u2019Regan L, Sabir SR, Bayliss R. Cell cycle regulation by the NEK family of protein kinases. J. Cell Sci.<\/i>, 125<\/b>, 4423\u20134433 (2012).","DOI":"10.1242\/jcs.111195"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kawashima A, Karasawa T, Tago K, Kimura H, Kamata R, Usui-Kawanishi F, Watanabe S, Ohta S, Funakoshi-Tago M, Yanagisawa K, Kasahara T, Suzuki K, Takahashi M. ARIH2 ubiquitinates NLRP3 and negatively regulates NLRP3 inflammasome activation in macrophages. J. Immunol.<\/i>, 199<\/b>, 3614\u20133622 (2017).","DOI":"10.4049\/jimmunol.1700184"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Karasawa T, Kawashima A, Usui F, Kimura H, Shirasuna K, Inoue Y, Komada T, Kobayashi M, Mizushina Y, Sagara J, Takahashi M. Oligomerized CARD16 promotes caspase-1 assembly and IL-1beta processing. FEBS Open Bio<\/i>, 5<\/b>, 348\u2013356 (2015).","DOI":"10.1016\/j.fob.2015.04.011"},{"key":"24","unstructured":"24) Rathinam VA, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell<\/i>, 165<\/b>, 792\u2013800 (2016)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Van Tassell BW, Toldo S, Mezzaroma E, Abbate A. Targeting interleukin-1 in heart disease. Circulation<\/i>, 128<\/b>, 1910\u20131923 (2013).","DOI":"10.1161\/CIRCULATIONAHA.113.003199"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Mezzaroma E, Toldo S, Farkas D, Seropian IM, Van Tassell BW, Salloum FN, Kannan HR, Menna AC, Voelkel NF, Abbate A. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 108<\/b>, 19725\u201319730 (2011).","DOI":"10.1073\/pnas.1108586108"},{"key":"27","unstructured":"27) Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ. Res.<\/i>, 105<\/b>, 1164\u20131176 (2009)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Sandanger \u00d8, Ranheim T, Vinge LE, Bliksoen M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G, Espevik T, Aukrust P, Yndestad A. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc. Res.<\/i>, 99<\/b>, 164\u2013174 (2013).","DOI":"10.1093\/cvr\/cvt091"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Venkatachalam K, Prabhu SD, Reddy VS, Boylston WH, Valente AJ, Chandrasekar B. Neutralization of interleukin-18 ameliorates ischemia\/reperfusion-induced myocardial injury. J. Biol. Chem.<\/i>, 284<\/b>, 7853\u20137865 (2009).","DOI":"10.1074\/jbc.M808824200"},{"key":"30","unstructured":"30) Shao BZ, Xu ZQ, Han BZ, Su DF, Liu C. NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol.<\/i>, 6<\/b>, 262 (2015)."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Toldo S, Abbate A. The NLRP3 inflammasome in acute myocardial infarction. Nat. Rev. Cardiol.<\/i>, 15<\/b>, 203\u2013214 (2018).","DOI":"10.1038\/nrcardio.2017.161"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Abbate A, Kontos MC, Grizzard JD, Biondi-Zoccai GG, Van Tassell BW, Robati R, Roach LM, Arena RA, Roberts CS, Varma A, Gelwix CC, Salloum FN, Hastillo A, Dinarello CA, Vetrovec GW; VCU-ART Investigators. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am. J. Cardiol.<\/i>, 105<\/b>, 1371\u20131377.e1 (2010).","DOI":"10.1016\/j.amjcard.2009.12.059"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Abbate A, Van Tassell BW, Biondi-Zoccai G, Kontos MC, Grizzard JD, Spillman DW, Oddi C, Roberts CS, Melchior RD, Mueller GH, Abouzaki NA, Rengel LR, Varma A, Gambill ML, Falcao RA, Voelkel NF, Dinarello CA, Vetrovec GW. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. Am. J. Cardiol.<\/i>, 111<\/b>, 1394\u20131400 (2013).","DOI":"10.1016\/j.amjcard.2013.01.287"},{"key":"34","unstructured":"34) Morton AC, Rothman AM, Greenwood JP, Gunn J, Chase A, Clarke B, Hall AS, Fox K, Foley C, Banya W, Wang D, Flather MD, Crossman DC. The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study. Eur. Heart J.<\/i>, 36<\/b>, 377\u2013384 (2015)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, Group CT. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med.<\/i>, 377<\/b>, 1119\u20131131 (2017).","DOI":"10.1056\/NEJMoa1707914"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle\u2013Wells syndrome. Nat. Genet.<\/i>, 29<\/b>, 301\u2013305 (2001).","DOI":"10.1038\/ng756"},{"key":"37","unstructured":"37) Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell<\/i>, 117<\/b>, 561\u2013574 (2004)."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T, Akira S. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol.<\/i>, 14<\/b>, 454\u2013460 (2013).","DOI":"10.1038\/ni.2550"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Fujisue K, Sugamura K, Kurokawa H, Matsubara J, Ishii M, Izumiya Y, Kaikita K, Sugiyama S. Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction. Circ. J.<\/i>, 81<\/b>, 1174\u20131182 (2017).","DOI":"10.1253\/circj.CJ-16-0949"},{"key":"40","unstructured":"40) Deftereos S, Giannopoulos G, Angelidis C, Alexopoulos N, Filippatos G, Papoutsidakis N, Sianos G, Goudevenos J, Alexopoulos D, Pyrgakis V, Cleman MW, Manolis AS, Tousoulis D, Lekakis J. Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study. Circulation<\/i>, 132<\/b>, 1395\u20131403 (2015)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/4\/42_b18-00369\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:31:33Z","timestamp":1559345493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/4\/42_b18-00369\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00369","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}